- Who we areWho we are
We are a biotechnology company committed to helping address serious infectious diseases globally through the discovery and development of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
- What we doWhat we do
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
COVID-19 UPDATESNovavax has demonstrated its ability to quickly develop viable vaccine candidates for emerging infectious diseases such as COVID-19.
- Blog
Novavax CEO Appointed to U.S.-India CEO Forum
Novavax today announced that Stanley C. Erck, President and Chief Executive Officer, Novavax, has been appointed by U.S. Secretary of Commerce Gina Raimondo to the U.S.-India CEO Forum (Forum) which brings together top-level business executives to discuss ways to strengthen the economic and commercial ties between the two countries, and to communicate their joint recommendations to the U.S. and Indian governments.
This appointment will provide Novavax’ CEO with the opportunity to lend insights based on his background of working extensively with some of India’s top business leaders. Further, Novavax will be a contributing partner in strengthening U.S. relationships with leaders in India and in a wide range of industries.
Established in 2005, the U.S.-India CEO Forum also informs government-to-government discussions, such as the U.S.-India Commercial Dialogue, on commercial affairs and highlights the strategic importance of the bilateral relationship.
